Daniel J. O'Connell
CEO & DirectorMr. Daniel J. O’Connell, also known as Dan, MBA was a Key Advisor at Acidophil, LLC. He served as President until February 01, 2024 and serves as Chief Executive Officer of Acumen Pharmaceuticals, Inc. since December 2014 and serves as its Director since April 2006. Mr. O’Connell is a founding member and former managing partner of NeuroVentures Capital, LLC, which he helped to established in 2001. Mr. O'Connell is a Managing Partner of Setagon, Inc. He co-founded MedSpecialists, Inc., and Surgical Solutions, LLC. He also co-founded and was the start-up CEO of Functional NeuroModulation Ltd. Mr. O’Connell is also a co-founder and acting CEO of Direct Spinal Therapeutics, Inc. Prior to attending business school, he worked in investment banking at Advest, Inc. At Advest, Mr. O’Connell assisted start up and emerging growth healthcare and technology companies with raising capital through public offerings and private placements and executing merger and acquisition transactions. He served as a Vice President of Business Development and Finance of MedSpecialists Inc. He represents NeuroVentures Capital LLC on the Board of Setagon Inc. Mr. O'Connell serves as the Executive Director of Direct Spinal Therapeutics, Inc. In addition, he serves as a Board Observer at BrainCells Inc., Concentric Medical Inc., NeurAxon Inc. and Rivanna Pharmaceuticals. He serves on the Board of the Epilepsy Foundation and as a Business Advisor to the Alzheimer’s Drug Development Fund. He serves as a Director of Setagon, Inc. He serves on the Advisory Board of the Wyss Center. He is a Member of the Business Advisory Boards of the Epilepsy Therapy Development Project and the Alzheimer's Drug Discovery Foundation. Mr. O’Connell serves on the Board of the Neurotechnology Industry Organization. Mr. O’Connell was previously a Board Observer of Cyberkinetics Neurotechnology Systems. He has experience in early-stage venture creation and investment with an emphasis on working with start-up life sciences companies and their scientific and entrepreneurial founders. Mr. O’Connell has experience with neuro-related technology companies. He received an M.B.A. from the University of Virginia and a B.A. from Brown University.
Positions
- Company NameAcumen Pharmaceuticals, Inc.Stock CodeABOSPositionCEO & DirectorColleagues
- GSGeorge S. GolumbeskiIndependent Chairman of the Board
- JDJames DohertyPresident & Chief Development Officer
- MZMatt ZugaCFO & Chief Business Officer
- GAGrant A. KrafftCo-Founder
- CECaleb E. FinchCo-Founder
- JLJeffrey L. C. IvesIndependent Director
- LSLaura StoppelIndependent Director
- KCKimberlee Cobleigh DrapkinIndependent Director
